<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00992082</url>
  </required_header>
  <id_info>
    <org_study_id>RAK-Spinal</org_study_id>
    <nct_id>NCT00992082</nct_id>
  </id_info>
  <brief_title>Local Infiltration Analgesia or Intrathecal Morphine in Total Knee Arthroplasty</brief_title>
  <official_title>Local Infiltration Analgesia or Intrathecal Morphine in Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Örebro County</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Örebro County</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether local infiltration analgesia is more
      effective than intrathecal morphine in reducing postoperative pain in total knee
      arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative pain is often severe following total knee arthroplasty. Spinal anesthesia is a
      common method in total knee arthroplasty. Adding morphine to the local anesthetic injected
      intrathecally prolongs the analgetic effect, but may give the usual opioid side effects. The
      Local Infiltration Analgesia (LIA) technique has proven effective in reducing postoperative
      pain in total knee arthroplasty. In the LIA technique a long-acting local anesthetic
      (ropivacaine), a nonsteroidal anti-inflammatory drug (ketorolac), and epinephrine are
      infiltrated intraoperatively and via an intraarticular catheter postoperatively.

      The aim of this study is to evaluate if spinal anesthesia together with the LIA technique
      provide better postoperative pain relief and mobilization than spinal anesthesia with
      addition of morphine to the local anesthetic intrathecally. Primary end-point is morphine
      consumption the first 48 postoperative hours. Secondary end-points are pain intensity, knee
      function, time to home readiness, hospital stay, side effects and patient satisfaction.
      Patients are followed up to 3 months after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2009</start_date>
  <completion_date type="Anticipated">August 2011</completion_date>
  <primary_completion_date type="Anticipated">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morphine consumption</measure>
    <time_frame>The first 48 postoperative hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>0-3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee function</measure>
    <time_frame>0-3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to home readiness</measure>
    <time_frame>0-2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>0-2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>0-3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>0-3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Group LIA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Local Infiltration Analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group M</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intrathecal morphine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine, ketorolac and epinephrine</intervention_name>
    <description>Spinal injection: bupivacaine 17.5 mg (3,5 mL) + 0.25 mL 0.9% saline. Local Infiltration Analgesia: 400 mg ropivacaine, 30 mg ketorolac and 0.5 mg epinephrine (total volume 166 ml) are infiltrated by the surgeon into the soft tissues peri-articularly during the operation. On the first and on the second postoperative morning, 200 mg ropivacaine, 30 mg ketorolac and 0.1 mg epinephrine, total volume 22 ml, are injected intraarticularly via the catheter.</description>
    <arm_group_label>Group LIA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>morphine</intervention_name>
    <description>Spinal injection: bupivacaine 17.5 mg (3.5 mL) + 0.1 mg (0.25 mL) morphine. No intraarticular injections are given.</description>
    <arm_group_label>Group M</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for total knee arthroplasty under spinal anesthesia.

          -  Aged 40-85 yrs.

          -  ASA physical status I-III and mobility indicating normal postoperative mobilization.

        Exclusion Criteria:

          -  Known allergy or intolerance to one of the study drugs.

          -  Serious liver-, heart- or renal decease.

          -  Rheumatoid arthritis.

          -  Chronic pain or bleeding disorder.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Per Essving, MD</last_name>
    <phone>+4619602100</phone>
    <email>per.essving@orebroll.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kjell Axelsson, Professor</last_name>
    <phone>+4619602100</phone>
    <email>kjell.axelsson@orebroll.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. of Orthopedic Surgery</name>
      <address>
        <city>Orebro</city>
        <zip>SE-70185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Per Essving, MD</last_name>
      <phone>+4619602100</phone>
      <email>per.essving@orebroll.se</email>
    </contact>
    <contact_backup>
      <last_name>Kjell Axelsson, Professor</last_name>
      <phone>+4619602100</phone>
      <email>kjell.axelsson@orebroll.se</email>
    </contact_backup>
    <investigator>
      <last_name>Kjell Axelsson, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2009</study_first_submitted>
  <study_first_submitted_qc>October 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2009</study_first_posted>
  <last_update_submitted>October 8, 2009</last_update_submitted>
  <last_update_submitted_qc>October 8, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 9, 2009</last_update_posted>
  <responsible_party>
    <name_title>Professor Kjell Axelsson</name_title>
    <organization>University Hospital Orebro</organization>
  </responsible_party>
  <keyword>Postoperative pain</keyword>
  <keyword>Local Infiltration Analgesia</keyword>
  <keyword>Knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

